Cineworld, the beleaguered London-listed global cinema group long targeted by hedge fund short sellers, has been dealt a fresh blow as a result of the Covid-19 pandemic, reporting a USD1.6 billion first-half loss with revenues plummeting after theatres were forced to close.
“No beliefs, only processes”: How French hedge fund Quantology’s machine-based model is reaping rewards
“Our motto is: ‘no beliefs, only processes’,” says Julien Messias, portfolio manager and co-founder of French systematic hedge fund Quantology Capital Management. “We are agnostic as to where the market will go – it is impossible to forecast. So what we trust are our processes.”
The Tungsten TRYCON AI Global Markets Find, which was one of the first AI-based UCITS strategies when it launched back in 2013 is up 4.1 per cent YTD in 2020. In the drawdown period up to March, when many portfolios suffered considerable losses, it was able to generate a gain of over 5 per cent.
The team behind the Lyxor Chenavari UCITS fund is repositioning the strategy for upcoming alpha-generating opportunities arising from the “choppy waters” of the forthcoming US election and Brexit.
Licensed fund manager, The Panxora Group, is now accepting subscriptions for the launch of a quantitative hedge fund designed to generate profits from the rapidly growing decentralised finance or (DeFi) token market. The fund will start trading on Monday, 2 November, 2020.
With the ripple effect of Covid-19 still being felt in the global economy, investment opportunities in high yield credit, and in particular distressed credit, have been numerous as investors seek out higher yield, at a commensurate higher risk.
Tellworth Investments has launched the The Tellworth British Recovery & Growth Trust, which commenced its initial public offering on 16 September 2020.
Hedge funds pile into Nikola short positions, as e-vehicle maker’s founder resigns amid fraud allegations
Hedge fund short sellers are circling Nikola Corporation, the electric vehicle and component manufacturer at the centre of fraud allegations, with the Nasdaq-listed firm’s share price tipped to tumble this week following executive chairman Trevor Milton’s sudden resignation on Sunday night (20 September).
Hickory Lane Capital Management, a New York-based fundamental equities-focused investment manager, is tapping into opportunities across the TMT, industrials and consumer sectors with a new long/short equity strategy, which has launched with USD100 million in assets anchored by asset management seeder Investcorp-Tages.
“A psychological placebo”: Why this hedge fund manager is betting against drug companies in the race for a Covid vaccine
The frantic hunt for an effective vaccine against coronavirus could leave some pharmaceutical companies highly exposed in a fiercely competitive race – and UK hedge fund Argonaut Capital is weighing in with several key bets against the sector.